Hostname: page-component-77f85d65b8-jkvpf Total loading time: 0 Render date: 2026-03-27T17:02:24.821Z Has data issue: false hasContentIssue false

Crystal structure of repotrectinib, C18H18FN5O2

Published online by Cambridge University Press:  20 June 2025

James A. Kaduk*
Affiliation:
Department of Chemistry, Illinois Institute of Technology , 3101 South Dearborn Street, Chicago, IL 60616, USA Department of Physics, North Central College, 131 South Loomis Street, Naperville, IL 60540, USA
Anja Dosen
Affiliation:
International Centre for Diffraction Data (ICDD) , 12 Campus Boulevard, Newtown Square, PA 19073-3273, USA
Tom Blanton
Affiliation:
International Centre for Diffraction Data (ICDD) , 12 Campus Boulevard, Newtown Square, PA 19073-3273, USA
*
Corresponding author: James A. Kaduk; Email: kaduk@polycrystallography.com

Abstract

The crystal structure of repotrectinib has been solved and refined using synchrotron X-ray powder diffraction data and optimized using density functional theory techniques. Repotrectinib crystallizes in the space group P212121 (#19) with a = 9.27406(5), b = 11.60810(8), c = 15.63623(8) Å, V = 1,683.306(20) Å3, and Z = 4 at 298 K. The crystal structure consists of stacks of V-shaped molecules along the b-axis. One amino group acts as a donor to the carbonyl group to link the molecules into chains along the a-axis with a graph set C1,1(8). The second amino group forms two intramolecular hydrogen bonds. The powder pattern has been submitted to the International Centre for Diffraction Data for inclusion in the Powder Diffraction File (PDF®).

Information

Type
New Diffraction Data
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© The Author(s), 2025. Published by Cambridge University Press on behalf of International Centre for Diffraction Data
Figure 0

Figure 1. The two-dimensional structure of repotrectinib.

Figure 1

Figure 2. The Rietveld plot for repotrectinib. The blue crosses represent the observed data points, and the green line represents the calculated pattern. The cyan curve represents the normalized error plot, and the red line represents the background curve. The blue tick marks indicate the repotrectinib peak positions. The vertical scale has been multiplied by a factor of 10× for 2θ > 24.0̊.

Figure 2

Figure 3. Comparison of the synchrotron pattern from this study of repotrectinib (black) to the laboratory pattern reported by Cui and Rogers (2019) (green). The literature pattern (measured using Cu Kα radiation) was digitized using UN-SCAN-IT (Silk Scientific, 2013) and converted to the synchrotron wavelength of 0.819563(2) Å using JADE Pro (MDI, 2024). Image generated using JADE Pro (MDI, 2024).

Figure 3

Figure 4. Comparison of the Rietveld-refined (red) and VASP-optimized (blue) structures of the repotrectinib molecule. The root-mean-square Cartesian displacement is 0.051 Å. Image generated using Mercury (Macrae et al., 2020).

Figure 4

Figure 5. The asymmetric unit of repotrectinib, with the atom numbering. The atoms are represented by 50% probability spheroids. Image generated using Mercury (Macrae et al., 2020).

Figure 5

Figure 6. The crystal structure of repotrectinib, viewed down the a-axis. Image generated using Diamond (Crystal Impact, 2023).

Figure 6

TABLE I. Hydrogen bonds (CRYSTAL23) in repotrectinib

Figure 7

Figure 7. The Hirshfeld surface of repotrectinib. Intermolecular contacts longer than the sums of the van der Waals radii are colored blue/gray, and contacts shorter than the sums of the radii are colored red. Contacts equal to the sums of radii are white. Image generated using CrystalExplorer (Spackman et al., 2021).